Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 911-920 of 2916 for cancer

Edit search filters
  1. A Study Of Unesbulin In Participants With Advanced Leiomyosarcoma (LMS)

    Jacksonville, FL

  2. Study Of 225Ac-ABD147 To Establish Optimal Dose In Patients With SCLC And LCNEC Of The Lung That Previously Received Platinum-based Chemotherapy

    Jacksonville, FL, Rochester, MN

  3. Gemcitabine Hydrochloride In Treating Patients With Locally Advanced Pancreatic Cancer

    Rochester, MN

  4. JAB-3312 Based Combination Therapy In Adult Patients With Advanced Solid Tumors

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  5. A Study Evaluating Temozolomide Vs. Temozolomide And Olaparib For Advanced Pheochromocytoma And Paraganglioma

    Rochester, MN

  6. A Study Of MBG453 In Combination With Azacitidine And Venetoclax In AML Patients Unfit For Chemotherapy

    Rochester, MN

  7. Study Of SAR444881 Administered Alone And In Combination With Other Therapeutics In Participants With Advanced Solid Tumors

    Scottsdale/Phoenix, AZ, Rochester, MN

  8. A Study Of CTX-712 In Relapsed/Refractory Acute Myeloid Leukemia And Higher Risk Myelodysplastic Syndromes

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  9. A Phase 2b Clinical Study With A Combination Immunotherapy In Newly Diagnosed Patients With Glioblastoma - The ImmuneSense Study

    Jacksonville, FL

  10. Quizartinib Or Placebo Plus Chemotherapy In Newly Diagnosed Patients With FLT3-ITD Negative AML

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

.

Mayo Clinic Footer